drugset / Trial / NCT00399438
A Study of BMS-562086 in Patients With Irritable Bowel Syndrome
RandomizedParallel-groupDouble-blind
Summary
The primary purpose of this study is to evaluate the effects of BMS-562086 on small bowel and colonic transits in female subjects with diarrhea-predominant irritable bowel syndrome (D-IBS)
Timeline
- Start
- 2006-12
- Primary completion
- 2007-10
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pexacerfont | Small molecule | 25 mg | Oral |
| Subject | Pexacerfont | Small molecule | 100 mg | Oral |